Cutler Group LP Myovant Sciences Ltd. Transaction History

Cutler Group LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	BUY	$24.03 - $27.02 $54,235 - $60,984	2,257 Added 72.76%	5,359 $144,000
Q3 2022 Oct 25, 2022	BUY	$11.6 - $20.44 $14,256 - $25,120	1,229 Added 65.62%	3,102 $55,000
Q2 2022 Aug 04, 2022	SELL	$7.78 - $14.69 $35,025 - $66,134	-4,502 Reduced 70.62%	1,873 $23,000
Q1 2022 Apr 14, 2022	BUY	$11.38 - $16.4 $72,547 - $104,549	6,375 New	6,375 $84,000
Q4 2021 Jan 18, 2022	SELL	$14.31 - $23.87 $1,431 - $2,387	-100 Closed	0 $0
Q3 2021 Oct 26, 2021	SELL	$18.94 - $26.99 $5,682 - $8,096	-300 Reduced 75.0%	100 $2,000
Q2 2021 Jul 19, 2021	SELL	$17.07 - $24.56 $33,184 - $47,744	-1,944 Reduced 82.94%	400 $9,000
Q4 2020 Jan 21, 2021	SELL	$13.8 - $27.62 $20,700 - $41,430	-1,500 Reduced 39.02%	2,344 $64,000
Q3 2020 Oct 27, 2020	BUY	$14.05 - $22.6 $49,793 - $80,094	3,544 Added 1181.33%	3,844 $54,000
Q1 2020 May 07, 2020	BUY	$6.55 - $14.76 $1,965 - $4,428	300 New	300 $2,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.